MMP9 and cancer: Knowledge of disease-related protease activity can be integrated into the design of nanosensor libraries that measure protease activity and these ABNs (activity-based nanosensors) have great potential to reveal disease-associated protease activity, as demonstrated by detection of MMP-9, a protease commonly upregulated in human cancers [291].